glp-1 balance and energy balance: an integrated model of short-term and long-term control Clostridium butyricum GLP-Activate: Daily Metabolism & Weight

References : These data were previously presented in abstract form at World Parkinsons Congress, Portland OR, 2016

If you were B12-deficient, the first week often brings less fatigue and better workout tolerance

Today Ely Lilly (LLY) announced the positive results on a phase 2 diabetes drug of theirs ( LY3298176 ) via a publication in The Lancet, a presentation at the annual meeting of the European Association for the Study of Diabetes (EASD) and the press release below: Lilly's Investigational Dual GIP and GLP-1 Receptor Agonist Shows Significant Reduction in HbA1c and Body Weight in People With Type 2 Diabetes The press release created a few headlines: Bloomberg: Diabetes Drug's Results Push Lilly to Look at Obesity Too Reuters: Lilly's diabetes drug data impresses, hurts rival Novo's shares The share price of Eli Lilly went up by 4% in an otherwise sour market and that of Danish rival Novo Nordisk (NOVO-B.CO) plummeted some 7-8%

While not primarily a fat loss compound, these effects support body recomposition when combined with appropriate training and nutrition

doi:10.1007/s12031-023-02164-5 Sun-Edelstein C, Mauskop A

Hesselink, M